Bevin is a research associate in the group using proteomics to identify and validate novel serum/plasma biomarker candidates for liver fibrosis in hepatitis C patients1, 2, 3, 4, 5, 6. He carried out his DPhil in the Zitzmann group where he used 2D-PAGE to identify serum biomarker candidates for liver fibrosis7.
Before joining the Zitzmann group he obtained his BSc (Hon) in Medical Biochemistry at the University of Surrey with his dissertation on investigating different membrane compositions for the optimisation of biosensors8. During his BSc he carried out his Professional Training at SmithKline Beecham and GlaxoSmithKline where he looked at ways of improving the representation of low abundant plasma proteins by depleting high abundant proteins and also compared different protein gel stains9.
Bevin works with others in the group and collaborators to help use proteomics to investigate several viral systems. This includes the identification of protein expression changes in cells infected with HCV10, hepatitis B virus11, herpes simplex virus12 and also using proteomics to investigate cell signalling in HIV13. Bevin is also on the editorial board for Biomarker Research and gives proteomics lectures to students in the department.